Electronic Data Capture (EDC) Systems and Part 11 Compliance
|
|
- Maryann Henderson
- 6 years ago
- Views:
Transcription
1 Electronic Data Capture (EDC) Systems and Part 11 Compliance Office of New Animal Drug Evaluation Center for Veterinary Medicine Society of Quality Assurance Gaylord Hotel, Washington DC March 28, 2017 Presenters: Ana Lazo, BS, RQAP GLP: Quality Assurance Study Reviewer Stefanie Cook, BS, RQAP GLP: Quality Assurance Study Reviewer
2 Copies of Raw Data submitted to CVM Two different types of raw data are submitted to CVM Manual (hand written) Data Collection Electronic Data Capture 2
3 Manual raw data submitted to CVM Manual data are collected via hand writing with indelible ink on paper and copies of manual raw data should be submitted to CVM as scanned copies in PDF format Examples: animal receipt records, test article accountability logs, analytical standard and QC preparations, paper data capture forms All copies of raw data submitted with critical studies should ensure any change is clearly denoted, legible, and attributable 3
4 Electronic Data Capture (EDC) systems The use of Electronic Data Capture (EDC) systems is on the rise CVM can only accept certain file types to meet our record retention requirements Require that copies of electronic data be submitted in nonproprietary Extensible Markup Language (XML), SAS XPORT (XPT) format, or possibly Portable Document Format (PDF) in order to secure longevity of the data Include audit trails from these systems CVM continues to work with EDC vendors and learn more about the capabilities of their systems to meet our file submission requirements 4
5 Types of Electronic Data Different types of electronic data Static data: data that cannot be altered or changed once recorded Collected via an automated data collection system or instrument e.g., hematology, data loggers, EKG Results may be printed or an electronic file of the raw data maybe available For systems that only permit printing of the data, copies of the raw data are submitted as PDFs For systems that permit exporting data in an electronic file, the raw data are submitted in PDF format and the in XML to permit electronic analysis and manipulation 5
6 Types of Electronic Data Different types of electronic data, cont. Dynamic data: e data that allows interaction between the user and the record content Collected via an electronic data capture system Results are electronic and the electronic file of the data should be available Copies of the raw data are electronic, i.e., XML, XPT or PDF, e.g., chromatograms, ECG charts 6
7 Types of Electronic Data Both static and dynamic data can be collected in a study. How these various types of data are used in a study should be clearly described. A description of how the data integrity is maintained when information is converted to a format different from that used for original capture should be provided. 7
8 Examples of Data Movement: Collection to Submission 8
9 CVM Review of Electronic Data Ultimate goal: The raw data should be reflected accurately in the final study report and CVM must be able to assure the veracity and integrity of the submitted data, both manual and electronic. 9
10 CVM Review of Electronic Data We must be able to navigate data files in order to locate data that correlates with protocol required activities, time points, treatments, etc. We need the actual electronic data points, not line listings 10
11 Electronic Data: How can you help us? Include in the final study report Names of data acquisition systems used and the data collected by each system A statement indicating the system(s) and/or equipment were validated and/or calibrated as appropriate Clearly identify data collected manually vs. electronically Identify data collected manually and later transcribed for review and the QC procedures used to verify the accuracy of the transcription * We will continue to work on where we want to be by identifying what crucial data needs to be submitted and what would be the best way to get it. 11
12 21 CFR Part 11 Awareness Electronic data capture systems are required to be compliant with Part 11 when the data collected from those systems are used in lieu of paper records or submitted to FDA Increased use of EDCs causing us to remind sponsors of their obligations under Part 11 (Electronic Records; Electronic Signatures) Agency has two GFIs on this topic Part 11, Electronic Records; Electronic Signatures Scope and Application 2003 Computerized Systems Used in Clinical Investigations 2007 Have begun asking sponsor whether the EDC systems used in their studies are Part 11 compliant 12
13 21 CFR Part 11 Scope Sec. 11.1(b) This part applies to records in electronic form that are created, modified, maintained, archived, retrieved, or transmitted, under any records requirements set forth in agency regulations. This part also applies to electronic records submitted to the agency under requirements of the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, even if such records are not specifically identified in agency regulations. 13
14 21 CFR Part 11 Scope Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application This document provides guidance to persons who, in fulfillment of a requirement in a statute or another part of FDA's regulations to maintain records or submit information to FDA, have chosen to maintain the records or submit designated information electronically and, as a result, have become subject to part 11. Part 11 applies to records in electronic form that are created, modified, maintained, archived, retrieved, or transmitted under any records requirements set forth in Agency regulations. Part 11 also applies to electronic records submitted to the Agency under the Federal Food, Drug, and Cosmetic Act (the Act) and the Public Health Service Act (the PHS Act), even if such records are not specifically identified in Agency regulations ( 11.1). 14
15 21 CFR Part 11 Awareness For GLP Studies: Your GLP compliance statements imply compliance with Part 11 Any systems that are not Part 11 compliant must be included as an exception to the GLP compliance statements Additionally, describe the vulnerabilities of the system(s) and how you have ensured that the system is adequate for its use For Clinical Studies: You should describe the Part 11 compliance status of all systems used in your study Can be included in the FSR As with GLP studies, describe vulnerabilities of non compliant systems and how you have ensured that the system is adequate for its use 15
16 21 CFR Part 11 Awareness Note that for both GLP and clinical studies we request: A description as to the Part 11 compliance of the data collection systems used during the study Another description as to the Part 11 compliance of the electronic files (XML, XPT, PDF) submitted to CVM 16
17 21 CFR Part 11 Awareness In these descriptions, for both GLP and GCP studies: We recommend describing the Part 11 compliance status for all electronic data capture in your submission Ensure that all EDC systems used are accounted for, both those used during the study and those used to prepare the data for submission to CVM Ensure that your descriptions includes the Part 11 compliance status of all electronic data you have submitted regardless of whether it was required by the predicate rule Ensure that your submission includes a description regarding the controls in place after export of your data from the controlled electronic environment in preparation for submission to CVM 17
18 21 CFR Part 11 Points to Consider Compliance must be maintained throughout the data lifecycle and should be considered during your validation process. Be sure that you are thinking of the following: Data collection Changes to the data Submission to CVM Archival 18
19 21 CFR Part 11 Points to Consider Ensure that your electronically recorded data retains all of the same attributes that are required of paper data. Retain these throughout the data lifecycle. ALCOA Attributable, Legible, Contemporaneous, Original and Accurate How do you maintain originality and all of the attributes of originality in an electronic world? Is data contemporaneously recorded if several data points are locked at once? How do you ensure all of these attributes are available for submission to CVM? 19
20 Questions? 20
21
Elements of Data Management
Elements of Data Management Disclaimers: The views in this presentation represent those of the presenter and not necessarily those of Bayer, CVM, SQA or KSU. Names used in examples are fictional and not
More informationWhite Paper Assessment of Veriteq viewlinc Environmental Monitoring System Compliance to 21 CFR Part 11Requirements
White Paper Assessment of Veriteq viewlinc Environmental Monitoring System Compliance to 21 CFR Part 11Requirements Introduction The 21 CFR Part 11 rule states that the FDA view is that the risks of falsification,
More informationAssessment of Vaisala Veriteq viewlinc Continuous Monitoring System Compliance to 21 CFR Part 11 Requirements
/ White PAPer Assessment of Vaisala Veriteq viewlinc Continuous Monitoring System Compliance to 21 CFR Part 11 Requirements The 21 CFR Part 11 rule states that the FDA view is that the risks of falsification,
More informationLeveraging ALCOA+ Principles to Establish a Data Lifecycle Approach for the Validation and Remediation of Data Integrity. Bradford Allen Genentech
Leveraging ALCOA+ Principles to Establish a Data Lifecycle Approach for the Validation and Remediation of Data Integrity Bradford Allen Genentech 1 Agenda Introduction Data Integrity 101 Review What is
More information21 CFR Part 11 LIMS Requirements Electronic signatures and records
21 CFR Part 11 LIMS Requirements Electronic signatures and records Compiled by Perry W. Burton Version 1.0, 16 August 2014 Table of contents 1. Purpose of this document... 1 1.1 Notes to version 1.0...
More informationWHITE PAPER AGILOFT COMPLIANCE WITH CFR 21 PART 11
WHITE PAPER AGILOFT COMPLIANCE WITH CFR 21 PART 11 with CFR 21 Part 11 Table of Contents with CFR 21 Part 11 3 Overview 3 Verifiable Support for End-User Requirements 3 Electronic Signature Support 3 Precise
More information21 CFR PART 11 FREQUENTLY ASKED QUESTIONS (FAQS)
21 CFR PART 11 FREQUENTLY ASKED QUESTIONS (S) The United States Food and Drug Administration (FDA) defines the criteria under which electronic records and electronic signatures are considered trustworthy,
More informationComply with Data Integrity Regulations with Chromeleon CDS Software
Comply with Data Integrity Regulations with Chromeleon CDS Software Anna Severoni Sales Support Specialist for Chromatography Thermo Fisher Scientific, Rodano (MI) The world leader in serving science Introduction
More informationData Integrity and the FDA AFDO Education Conference
Data Integrity and the FDA AFDO Education Conference June, 2018 OUR EXPERIENCE YOUR SUCCESS 1 Data Integrity What does it mean to you? 2 Data Integrity What does FDA say about data integrity No legal definition
More informationIntroduction. So what is 21 CFR Part 11? Who Should Comply with 21CFR Part 11?
Introduction The following guide is an explanation of the term 21 CFR Part 11, and gives some background into the tools/features that Comark includes in its 21 CFR Part 11 products to aid compliance with
More information21 CFR PART 11 COMPLIANCE
21 CFR PART 11 COMPLIANCE PRODUCT OVERVIEW ADD-ONS & INDIVIDUAL SOLUTIONS PLA SUPPORT CONTRACT TRAINING CONSULTING 21 CFR PART 11 COMPLIANCE PLA 3.0 Software For Biostatistical Analysis PLA 3.0 21 CFR
More informationCOMPLIANCE. associates VALIDATOR WHITE PAPER. Addressing 21 cfr Part 11
VALIDATOR WHITE PAPER Addressing 21 cfr Part 11 Compliance Associates 1 1 INTRODUCTION 21 CFR Part 11 has been become a very large concern in the pharmaceutical industry as of late due to pressure from
More informationCurrent Expectations and Guidance, including Data Integrity and Compliance With CGMP
Current Expectations and Guidance, including Data Integrity and Compliance With CGMP Sarah Barkow, PhD Team Lead, CDER/OC/OMQ Guidance & Policy International Society for Pharmaceutical Engineering Data
More informationData Integrity: Technical controls that demonstrate trust
WHITE PAPER 80077 Data Integrity: Technical controls that demonstrate trust Using Chromeleon 7 Chromatography Data System for enhanced data integrity Author Shaun Quinn, Marketing Manager Informatics and
More informationComplying with FDA's 21 CFR Part 11 Regulation
Complying with FDA's 21 CFR Part 11 Regulation A Secure Time Management Primer This report was prepared by the Washington Bureau of Larstan Business Reports, an independent editorial firm based in Washington,
More informationBioInformatics A Roadmap To Success. Data Management Plans. Wes Rountree Associate Director of Data Management Family Health International
BioInformatics A Roadmap To Success Data Management Plans Wes Rountree Associate Director of Data Management Family Health International What is a Data Management Plan? A document that describes how clinical
More informationAgilent Response to 21CFR Part11 requirements for the Agilent ChemStation Plus
Agilent Response to 21CFR Part11 requirements for the Agilent ChemStation Plus 1. Preface This document describes which requirements of the FDA s rule for electronic records and electronic signature (21
More informationData Integrity and Worldwide Regulatory Guidance
20 Data Integrity and Worldwide Regulatory Guidance Rohit A. Patil, Shruti N.Patil Department of Regulatory Affairs Supreme Pharma Healthcare Pvt. Ltd. Mumbai rohitpharma3250@gmail.com ABSTRACT Good storage
More informationThe Impact of 21 CFR Part 11 on Product Development
The Impact of 21 CFR Part 11 on Product Development Product development has become an increasingly critical factor in highly-regulated life sciences industries. Biotechnology, medical device, and pharmaceutical
More informationChromQuest 5.0. Tools to Aid in 21 CFR Part 11 Compliance. Introduction. General Overview. General Considerations
ChromQuest 5.0 Tools to Aid in 21 CFR Part 11 Compliance Introduction Thermo Scientific, Inc. is pleased to offer the ChromQuest chromatography data system (CDS) as a solution for chromatography labs seeking
More informationSparta Systems TrackWise Digital Solution
Systems TrackWise Digital Solution 21 CFR Part 11 and Annex 11 Assessment February 2018 Systems TrackWise Digital Solution Introduction The purpose of this document is to outline the roles and responsibilities
More informationUsing "TiNet 2.5 Compliant SR1" software to comply with 21 CFR Part 11
2003-08-08/dö Using "TiNet 2.5 Compliant SR1" software to comply with 21 CFR Part 11 The Title 21 Code of Federal Regulations Electronic Records; Electronic Signatures of the U.S. Food and Drug Administration,
More informationIntegration of Agilent OpenLAB CDS EZChrom Edition with OpenLAB ECM Compliance with 21 CFR Part 11
OpenLAB CDS Integration of Agilent OpenLAB CDS EZChrom Edition with OpenLAB ECM Compliance with 21 CFR Part 11 Technical Note Introduction Part 11 in Title 21 of the Code of Federal Regulations includes
More informationSDA COMPLIANCE SOFTWARE For Agilent ICP-MS MassHunter Software
SDA COMPLIANCE SOFTWARE For Agilent ICP-MS MassHunter Software Part 11 in Title 21 of the US Code of Federal Regulations (commonly referred to as 21 CFR Part 11) governs food and drugs in the US, and includes
More informationCompliance Matrix for 21 CFR Part 11: Electronic Records
Compliance Matrix for 21 CFR Part 11: Electronic Records Philip E. Plantz, PhD, Applications Manager David Kremer, Senior Software Engineer Application Note SL-AN-27 Revision B Provided By: Microtrac,
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry January Initial Review and Critique March 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 Initial Review and Critique March 2015 Bob McDowall R.D.McDowall Ltd Thanks to Mark Newton, Lorrie Schuessler & Chris Burgess
More informationMetrohm White paper. FDA 21 CFR Part 11 Requirements for NIR Spectroscopy. Dr. N. Rühl
FDA 21 CFR Part 11 Requirements for NIR Spectroscopy Dr. N. Rühl The prosperity of a society can be evaluated based on many criteria, and the focus is certainly different for each individual. However,
More informationOctober p. 01. GCP Update Data Integrity
p. 01 p. 02 p. 03 failures by organizations to: apply robust systems that inhibit data risks, improve the detection of situations where data reliability may be compromised, and/or investigate and address
More informationMicroLab FTIR Software 21 CFR Part 11 Compliance
MicroLab FTIR Software 21 CFR Part 11 Compliance Technical Overview Introduction Electronic data submitted to the United States FDA must comply with specifications set forth in the Code of Federal Regulations,
More informationOpenLAB ELN Supporting 21 CFR Part 11 Compliance
OpenLAB ELN Supporting 21 CFR Part 11 Compliance White Paper Overview Part 11 in Title 21 of the Code of Federal Regulations includes the US Federal guidelines for storing and protecting electronic records
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry March Introduction:
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationData Integrity for the Microbiology Laboratory
Data Integrity for the Microbiology Laboratory 1 Agenda Useful Sources of Information Define DATA ALCOA Principles Data Integrity Risks Regulatory Expectations Failure Mode and Effects Analysis 2 Disclaimer
More informationFDA XML Data Format Requirements Specification
FDA XML Data Format Barry Brown, Product Integration Manager, Mortara Instrument Mark Kohls, Engineering Director, GE Medical Systems-Information Technologies Norman Stockbridge, M.D., Ph. D., Medical
More informationData Integrity in Clinical Trials
Data Integrity in Clinical Trials DIA/ISPE Workshop 06-07 NOV 2014 Tom Haag, Novartis Pharmaceuticals Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual
More informationtesto Comfort Software CFR 4 Instruction manual
testo Comfort Software CFR 4 Instruction manual 2 1 Contents 1 Contents 1 Contents... 3 2 Specifications... 4 2.1. Intended purpose... 4 2.2. 21 CFR Part 11 and terminology used... 5 3 First steps... 9
More informationREGULATION ASPECTS 21 CFR PART11. 57, av. Général de Croutte TOULOUSE (FRANCE) (0) Fax +33 (0)
REGULATION ASPECTS 21 CFR PART11 57, av. Général de Croutte - 31100 TOULOUSE (FRANCE) - +33 (0)5 34 47 40 00 - Fax +33 (0)5 34 47 43 01 Trademarks All names identified by are registered trademarks of the
More informationIntroduction 2. History. Adapted to zenon version 6.20 (MH) January 13 th, 2006
FDA 21 CFR Part 11 Introduction 2 History Date January 13 th, 2006 Comment Adapted to zenon version 6.20 (MH) 1994 COPA-DATA GmbH All rights reserved. Distribution and/or reproduction of this document
More informationSparta Systems Stratas Solution
Systems Solution 21 CFR Part 11 and Annex 11 Assessment October 2017 Systems Solution Introduction The purpose of this document is to outline the roles and responsibilities for compliance with the FDA
More informationElectronic Data Processing 21 CFR Part 11
Live Webinar on How Does Compliance with 21 CFR Part 11 Ensure Data Integrity & Subject Safety in Clinical Research Wednesday, 19 June 2013 at 10:00 AM PST / 01:00 PM EST ByCharles H. Pierce, MD, PhD,
More informationSparta Systems TrackWise Solution
Systems Solution 21 CFR Part 11 and Annex 11 Assessment October 2017 Systems Solution Introduction The purpose of this document is to outline the roles and responsibilities for compliance with the FDA
More informationUsing "IC Net 2.2 " software to comply with 21 CFR Part 11
CH-9101 Herisau/Switzerland E-Mail info@metrohm.com Internet www.metrohm.com Using "IC Net 2.2 " software to comply with 21 CFR Part 11 Compliance white paper 8.110.8273 CH-9101 Herisau/Switzerland E-Mail
More informationZeroing in on Data Integrity within R&D. Timothy Cleary Vice President, Legal Affairs Sanofi Pasteur Inc.
Zeroing in on Data Integrity within R&D Timothy Cleary Vice President, Legal Affairs Sanofi Pasteur Inc. 1 Zeroing in on Data Integrity within R&D Data integrity is not a new concern, but FDA has a pronounced
More informationIn the first article in this series (1),
OCTOBER 2015 LCGC NORTH AMERICA VOLUME 33 NUMBER 10 1 The Ideal Chromatography Data System for a Regulated Laboratory, Part II: System Architecture Requirements Here in the second part of this series,
More informationUsing Chromeleon 7 Chromatography Data System to Comply with 21 CFR Part 11
WHITE PAPER 80078 Using Chromeleon 7 Chromatography Data System to Comply with 21 CFR Part 11 Author Shaun Quinn, Marketing Manager Informatics and Chromatography Software, Thermo Fisher Scientific Keywords
More informationGood Laboratory Practice GUIDELINES FOR THE ARCHIVING OF ELECTRONIC RAW DATA IN A GLP ENVIRONMENT. Release Date:
AGIT: Swiss Working Group on Information Technology in a GLP Environment Good Laboratory Practice GUIDELINES FOR THE ARCHIVING OF ELECTRONIC RAW DATA IN A GLP ENVIRONMENT Release Date: 31.01.2018 Version:
More informationClinical trial data management technology Guide
annex Clinical trial data management technology Guide I. Overview Clinical Trial Data quality is evaluated on the basis of clinical trial results. In order to ensure accurate and reliable results of clinical
More informationAdobe Sign and 21 CFR Part 11
Adobe Sign and 21 CFR Part 11 Today, organizations of all sizes are transforming manual paper-based processes into end-to-end digital experiences speeding signature processes by 500% with legal, trusted
More informationNucleoCounter NC-200, NucleoView NC-200 Software and Code of Federal Regulation 21 Part 11; Electronic Records, Electronic Signatures (21 CFR Part 11)
NucleoCounter NC-200, NucleoView NC-200 Software and Code of Federal Regulation 21 Part 11; Electronic Records, Electronic Signatures (21 CFR Part 11) A ChemoMetec A/S White Paper March 2014 ChemoMetec
More informationPart 11 Compliance SOP
1.0 Commercial in Confidence 16-Aug-2006 1 of 14 Part 11 Compliance SOP Document No: SOP_0130 Prepared by: David Brown Date: 16-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 16-Aug-2006 2 of 14 Document
More informationINFORMATION. Guidance on the use of the SM1000 and SM2000 Videographic Recorders for Electronic Record Keeping in FDA Approved Processes
INFORMATION No. INF02/70 Issue 3 Date: October 2007 Product SM1000 and SM2000 Videographic Recorders Manuals IM/SM1000 and IM/SM2000 Guidance on the use of the SM1000 and SM2000 Videographic Recorders
More informationTexas A&M University Controlled Substances Guidelines Training Module. September 2017
Texas A&M University Controlled Substances Guidelines Training Module September 2017 Applicability Guidelines for the purchase, storage, use, and disposal of controlled substances used in research and
More informationChapter 10: Regulatory Documentation
Table of Contents Chapter 10: Regulatory Documentation... 10-1 10.1 Regulatory Requirements:... 10-1 10.2 Ongoing Regulatory Documents:... 10-4 10.3 After study completion or termination of the trial...
More informationInformed Consent and the Consent Form
Informed Consent and the Consent Form What is informed consent? What does the process look like? Who can obtain consent? Where can I find more information? Consent Form Informed Consent They are NOT the
More informationSite User Guide. Oracle Health Sciences InForm CRF Submit Release Part Number:E
Site User Guide Oracle Health Sciences InForm CRF Submit Release 4.0.2 Part Number:E79080-01 Copyright 2016, 2017, Oracle and/or its affiliates. All rights reserved. This software and related documentation
More informationI-9 AND E-VERIFY VENDOR DUE DILIGENCE
I-9 AND E-VERIFY VENDOR DUE DILIGENCE WHITE PAPER I-9 and E-Verify Vendor Due Diligence Key questions to ask electronic I-9 vendors to ensure you are making the best choice for your business. 1. Vendor
More informationEUROPEAN MEDICINES AGENCY (EMA) CONSULTATION
EUROPEAN MEDICINES AGENCY (EMA) CONSULTATION Guideline on GCP compliance in relation to trial master file (paper and/or electronic) for content, management, archiving, audit and inspection of clinical
More informationAgilent ICP-MS ChemStation Complying with 21 CFR Part 11. Application Note. Overview
Agilent ICP-MS ChemStation Complying with 21 CFR Part 11 Application Note Overview Part 11 in Title 21 of the Code of Federal Regulations includes the US Federal guidelines for storing and protecting electronic
More informationAchieving 21 CFR Part 11 Compliance using CENTUM VP
Achieving 21 CFR Part 11 Compliance using CENTUM VP Authored by: Achieving 21 CFR 11 Compliance Table Of Contents 1 ABSTRACT...3 2 21 CFR PART 11 GENERAL REQUIREMENTS...3 2.1 WHY ELECTRONIC RECORDS & ELECTRONIC
More informationSummary of PIC/S Guidance Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments
www.rx-360.org Summary of PIC/S Guidance Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments Draft Published August 2016 This summary was prepared by the Rx-360 Monitoring
More informationBelow we ve highlighted several of the key points from the final guidance document.
On September 6, 2017, the Food and Drug Administration (FDA or the Agency) released its final guidance document, Design Considerations and Pre-Market Submission Recommendations for Interoperable Medical
More informationSITE FILE MANAGEMENT
SITE FILE MANAGEMENT STANDARD OPERATING PROCEDURE NO SOP 08 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES: To describe the procedure for the maintenance of essential documents
More informationPart 11 is Dead Long Live Part CFR 11, the Electronic Records and Electronic Signatures 21 CFR PART 11. Introduction
Part 11 is Dead Long Live Part 11 R.D. McDowall, Ph.D. McDowall Consulting Introduction 21 CFR 11, the Electronic Records and Electronic Signatures final rule [1], that is applicable to the pharmaceutical
More informationPurpose: To describe the requirements for managing IP at the clinical site
Title: Investigational Product Management Topic: Management of IP Effective Date: March 16, 2016 Approved By: Rita Hanson, M.D. Senior VP/Chief Medical Officer Purpose: To describe the requirements for
More informationIntegration of Agilent UV-Visible ChemStation with OpenLAB ECM
Integration of Agilent UV-Visible ChemStation with OpenLAB ECM Compliance with Introduction in Title 21 of the Code of Federal Regulations includes the US Federal guidelines for storing and protecting
More informationUsing the Titrando system to comply with 21 CFR Part 11
01.2003/sn Using the Titrando system to comply with 21 CFR Part 11 The Electronic Records and Signatures Rule, known as 21 CFR Part 11, was established by the U.S. Food and Drug Administration (FDA) to
More informationKEEPING YOUR RESEARCH SECURE AND COMPLIANT
KEEPING YOUR RESEARCH SECURE AND COMPLIANT Introduction to Archiving Because research records and materials are vital to drug development programs, it is fundamental that they be properly stored in a GLP-compliant
More informationAtmoCONTROL FDA EDITION IQ DOCUMENTATION OQ DOCUMENTATION 100% ATMOSAFE. MADE IN GERMANY.
AtmoCONTROL FDA EDITION IQ DOCUMENTATION OQ DOCUMENTATION 100% ATMOSAFE. MADE IN GERMANY. www.memmert.com www.atmosafe.net Manufacturer and customer service Memmert GmbH + Co. KG Willi-Memmert-Straße 90
More informationDataset-XML - A New CDISC Standard
Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML
More informationSpectroscopy Configuration Manager (SCM) Software. 21 CFR Part 11 Compliance Booklet
Spectroscopy Configuration Manager (SCM) Software 21 CFR Part 11 Compliance Booklet Notices Agilent Technologies, Inc. 2006-2007 and 2009-2011 No part of this manual may be reproduced in any form or by
More informationAdvantages of a real end-to-end approach with CDISC standards
Advantages of a real end-to-end approach with CDISC standards Dr. Philippe Verplancke CEO XClinical GmbH 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and opinions expressed
More informationStandard Operating Procedure. Data Management. Adapted with the kind permission of University Hospitals Bristol NHS Foundation Trust
Data Management REFERENCE: VERSION NUMBER: 2.1 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Clinical Trials Manager; Clinical Trials Officer REVIEWED BY: R&I Senior Team APPROVED BY: Deputy Director
More informationABB Limited. Table of Content. Executive Summary
21 CFR Part 11 Electronic Records; Electronic Signatures Guidance for Industry Scope of Application Position Paper: A Summary and Interpretation of the Guidance Note: This document has been prepared based
More informationTouchstone Technologies, Inc. Course Catalog February 2017
Touchstone Technologies, Inc. Course Catalog February 2017 Angela Bazigos ANGELA BAZIGOS 1 HR Courses Course Duration Audience Speaker 1. Basics of Project Management Webinar 90 mins Management Bazigos
More informationChanges and Additions from SoftMax Pro to SoftMax Pro 4.3.1
Changes and Additions from SoftMax Pro 4.3.0 to SoftMax Pro 4.3.1 The primary change to SoftMax Pro from versions 4.3.0 and 4.3.1 is the addition of support for FlexStation II and FlexStation II 384. FlexStation
More informationCurrent Expectations and Guidance Data Integrity
Current Expectations and Guidance Data Integrity by Pepe Rodriguez-Perez, PhD Business Excellence Consulting Inc www.calidadpr.com email training@calidadpr.com US FDA Guidance for Industry April 2016 This
More informationOASIS Electronic Trial Master File Standard Technical Committee
OASIS Electronic Trial Master File Standard Technical Committee Electronic and Digital Signatures Discussion March 3, 2014 9:00 10:00 AM PST Introducing Electronic and Digital Signatures Agenda Topic Presenter
More informationAchieving 21 CFR Part 11 Compliance using CENTUM VP
Achieving 21 CFR Part 11 Compliance using CENTUM VP Authored in cooperation with: Achieving 21 CFR 11 Compliance Table of Contents 1 ABSTRACT... 3 2 21 CFR PART 11 GENERAL REQUIREMENTS... 3 2.1 WHY ELECTRONIC
More informationCompliance of Shimadzu Total Organic Carbon (TOC) Analyzer with FDA 21 CFR Part 11 Regulations on Electronic Records and Electronic Signatures
NT1D-1275 Compliance of Shimadzu Total Organic Carbon (TOC) Analyzer with FDA 21 CFR Part 11 Regulations on Electronic Records and Electronic Signatures TOC-Control L Ver.1 / LabSolutions DB/CS Ver.6 Part
More informationGDUFA s Impact on ectds / Case Study: Implementing PDF Standards
GDUFA s Impact on ectds / Case Study: Implementing PDF Standards GPhA 2015 Fall Technical Conference GDUFA S Impact on ectds GPhA 2015 Fall Technical Conference 1 Introductions Kevin Tompkins Director,
More informationFRAMEWORK FOR THE DESTRUCTION OF PAPER
FRAMEWORK FOR THE DESTRUCTION OF PAPER Version v1.0 24 June 2012 Created through the DIA Document and Records Management (DRM) Special Interest Area Community (SIAC) TABLE OF CONTENTS Position Statement...
More informationDATA INTEGRITY (EMA AUGUST 2016)
Data integrity Data integrity enables good decision-making by pharmaceutical manufacturers and regulatory authorities.it is a fundamental requirement of the pharmaceutical quality system described in EU
More informationBiotechnology Industry Organization 1225 Eye Street NW, Suite 400 Washington, DC 20006
Biotechnology Industry Organization 1225 Eye Street NW, Suite 400 Washington, DC 20006 December 22, 2003 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville,
More information21 CFR 11 Assistant Software. 21 CFR Part 11 Compliance Booklet
21 CFR 11 Assistant Software 21 CFR Part 11 Compliance Booklet Notices Agilent Technologies, Inc. 2001-2004, 2009-2010 No part of this manual may be reproduced in any form or by any means (including electronic
More informationThe Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008
The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits
More informationApplication Note. This data also falls under FDA regulations for GLP and must comply with the guidelines for electronics records (21 CFR Part 11.
Using ChemStation Plus to Track Data from Drug Stability Studies Application Note Introduction Drug stability is one of the most often studied characteristics in pharmaceutical testing. Large numbers of
More informationAn Easy to Understand Guide 21 CFR Part 11
An Easy to Understand Guide 21 CFR Part 11 The Validation Specialists askaboutvalidation Connecting the Lifesciences An Easy to Understand Guide 21 CFR Part 11 Published by Premier Validation 21 CFR Part
More informationAutomation Change Management for Regulated Industries
Automation Change Management for Regulated Industries Achieving Part 11 Compliance A White Paper Synopsis This whitepaper provides information related to FDA regulation 21 CFR Part 11 (Part 11) for organizations
More informationStatement of 21 CFR Part 11 Validation Results
Statement of Validation Results Software application: Session Manager DB (TurboTag ) Sealed Air Corporation Version: 2.1.1.5 Status: Validated through version 2.1.1.5 (Original validation completed on
More informationFDA 21 CFR Part 11 Compliance by Metrohm Raman
FDA 21 CFR Part 11 Compliance by Metrohm Raman Norms and Standards 21 CFR Part 11 is the FDA rule relating to the use of electronic records and electronic signatures. Recognizing the increasing pact of
More informationTECHNICAL BULLETIN [ 1 / 13 ]
TECHNICAL BULLETIN [ 1 / 13 ] [Title] Guidelines on Compliance with FDA 21 CFR Part 11 for the GOT2000 and GOT1000 Series [Date of Issue] November 2014 (Ver. C: November 2017) [Relevant Models] GOT2000
More informationCost-Benefit Analysis of Retrospective vs. Prospective Data Standardization
Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization Vicki Seyfert-Margolis, PhD Senior Advisor, Science Innovation and Policy Food and Drug Administration IOM Sharing Clinical Research
More informationMedicines & Healthcare products Regulatory Agency (MHRA) GXP Data Integrity Guidance and Definitions
Medicines & Healthcare products Regulatory Agency (MHRA) GXP Data Integrity Guidance and Definitions March 2018 Page 1 of 21 Table of contents 1. Background... 3 2. Introduction... 3 3. The principles
More informationData Quality and Integrity Investigation in Laboratories (Analytical)
Data Quality and Integrity Investigation in Laboratories (Analytical) Dr. Ademola O. Daramola, DHSc., MPH Assistant Country Director International Relations Specialist (Drug) US FDA Office of International
More informationData Integrity for the Microbiology Laboratory
Data Integrity for the Microbiology Laboratory 1 Agenda Useful Sources of Information Define DATA ALCOA Principles Data Integrity Risks Regulatory Expectations Tools for Assessing Risk 2 Disclaimer These
More informationExample of QbD Application in Japan Yoshihiro Matsuda, Ph.D.
Example of QbD Application in Japan Yoshihiro Matsuda, Ph.D. Senior Scientist (for Quality) Pharmaceuticals and Medical Devices Agency (PMDA) Aug 11, 2016 1 Agenda Introduction of PMDA QbD assessment experience
More informationUsing the Titrando system to comply with 21 CFR Part 11
06.2006/jb Using the Titrando system to comply with 21 CFR Part 11 The Title 21 Code of Federal Regulations Electronic Records; Electronic Signatures of the U.S. Food and Drug Administration, known as
More informationRequest for Feedback. Manizhe Payton, MPH. Director Office of Clinical Site Oversight Division of AIDS February 22, 2017
Request for Feedback Manizhe Payton, MPH Director Office of Clinical Site Oversight Division of AIDS February 22, 2017 Background European Medicines Agency (EMA) inspected 2 clinical research sites in
More informationTHE TRIAL MASTER FILE
THE TRIAL MASTER FILE CONFIDENCE IN PROVIDING TMF FOR REGULATORY INSPECTION OR LEGAL DISCOVERY EXECUTIVE SUMMARY FOR EXL PHARMA S 2ND EUROPEAN TRIAL MASTER FILE SUMMIT LONDON OCTOBER 22 23, 2013 CONTENTS
More informationTechnical Note. Introduction
Integration of ChemStation with Agilent OL ECM Technical Note Introduction Agilent Enterprise Content Manager (ECM) is a web-based electronic library that provides a storage place for all electronic data.
More informationSeptember 26, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More information